Renin induces apoptosis in podocytes through a receptor-mediated, angiotensin II-independent mechanism

American Journal of the Medical Sciences

Volumn 344, Issue 6, 2012, Pages 441-446

  Yuan, Hai ^a   Ren, Zhi Long ^a   Hu, Feng Qi ^a   Liang, Wei ^a   Ding, Guo Hua ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Angiotensin II; Podocyte; Renin; Renin receptor

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANGIOTENSIN II; CASPASE 3; DNA; ENALAPRIL; LOSARTAN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; RENIN; SMALL INTERFERING RNA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL LINE; CONTROLLED STUDY; DISEASE COURSE; DOSE TIME EFFECT RELATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GLOMERULOSCLEROSIS; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASE; MOUSE; NONHUMAN; PATHOGENESIS; PODOCYTE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84870977572     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e318245fdaa     Document Type: Article

References (32)

1. Siragy HM, Carey RM. Role of the intrarenal renin-angiotensinaldosterone system in chronic kidney disease. Am J Nephrol 2010; 31: 541-50.
2. Huang Y, Noble NA, Zhang J, et al. Renin-stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cells. Kidney Int 2007;72: 45-52.
3. Huang Y, Wongamorntham S, Kasting J, et al. Renin increases mesangial cell transforming growth factor-beta1 and matrix proteins through receptor-mediated, angiotensin II-independent mechanisms. Kidney Int 2006;69: 105-13.
4. Nguyen G, Delarue F, Burckle C, et al. Pivotal role of the renin/ prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 2002;109: 1417-27.
5. Nguyen G. The (pro)renin receptor in health and disease. Ann Med 2010;42: 13-8.
6. Balakumar P, Jagadeesh G. Cardiovascular and renal pathologic implications of prorenin, renin, and the (pro)renin receptor: promising young players from the old renin-angiotensin-aldosterone system. J Cardiovasc Pharmacol 2010;56: 570-9.
7. Advani A, Kelly DJ, Cox AJ, et al. The (Pro)renin receptor: sitespecific and functional linkage to the vacuolar H+-ATPase in the kidney. Hypertension 2009;54: 261-9.
8. Sakoda M, Ichihara A, Kurauchi-Mito A, et al. Aliskiren inhibits intracellular angiotensin II levels without affecting (pro)renin receptor signals in human podocytes. Am J Hypertens 2010;23: 575-80.
9. Nguyen G, Delarue F, Berrou J, et al. Specific receptor binding of renin on human mesangial cells in culture increases plasminogen activator inhibitor-1 antigen. Kidney Int 1996;50: 1897-903.
10. Pavenstadt H, Kriz W, Kretzler M. Cell biology of the glomerular podocyte. Physiol Rev 2003;83: 253-307.
11. Chen C, Liang W, Jia J, et al. Aldosterone induces apoptosis in rat podocytes: role of PI3-K/Akt and p38MAPK signaling pathways. Nephron Exp Nephrol 2009;113: e26-34.
12. Ding G, Reddy K, Kapasi AA, et al. Angiotensin II induces apoptosis in rat glomerular epithelial cells. Am J Physiol Renal Physiol 2002;283: F173-80.
13. Jia J, Ding G, Zhu J, et al. Angiotensin II infusion induces nephrin expression changes and podocyte apoptosis. Am J Nephrol 2008;28: 500-7.
14. Liang W, Chen C, Shi J, et al. Disparate effects of eplerenone, amlodipine and telmisartan on podocyte injury in aldosterone-infused rats. Nephrol Dial Transplant 2011;26: 789-99.
15. Kaneshiro Y, Ichihara A, Sakoda M, et al. Slowly progressive, angiotensin II-independent glomerulosclerosis in human (pro)renin receptor-transgenic rats. J Am Soc Nephrol 2007;18: 1789-95.
16. Muller-Deile J, Worthmann K, Saleem M, et al. The balance of autocrine VEGF-A and VEGF-C determines podocyte survival. Am J Physiol Renal Physiol 2009;297: F1656-67.
17. Koshikawa M, Mukoyama M, Mori K, et al. Role of p38 mitogenactivated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome. J Am Soc Nephrol 2005;16: 2690-701.
18. Susztak K, Raff AC, Schiffer M, et al. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 2006;55: 225-33.
19. Nicholson DW, Ali A, Thornberry NA, et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995;376: 37-43.
20. Morishima N, Nakanishi K, Takenouchi H, et al. An endoplasmic reticulum stress-specific caspase cascade in apoptosis. Cytochrome c-independent activation of caspase-9 by caspase-12. J Biol Chem 2002;277: 34287-94.
21. Azizi M, Bissery A, Lamarre-Cliche M, et al. Integrating drug pharmacokinetics for phenotyping individual renin response to angiotensin II blockade in humans. Hypertension 2004;43: 785-90.
22. Kramer BK, Ritthaler T, Schweda F, et al. Effects of the angiotensin II type-1 receptor antagonist ZD7155 on angiotensin II-mediated regulation of renin secretion and renal renin gene expression, renal vasoconstriction, and blood pressure in rats. J Cardiovasc Pharmacol 1998;31: 700-5.
23. Johns DW, Peach MJ, Gomez RA, et al. Angiotensin II regulates renin gene expression. Am J Physiol 1990;259: F882-7.
24. Thornton TM, Rincon M. Non-classical p38 map kinase functions: cell cycle checkpoints and survival. Int J Biol Sci 2009;5: 44-51.
25. Nagase M, Shibata S, Yoshida S, et al. Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker. Hypertension 2006;47: 1084-93.
26. Buleon M, Allard J, Jaafar A, et al. Pharmacological blockade of B2- kinin receptor reduces renal protective effect of angiotensin-converting enzyme inhibition in db/db mice model. Am J Physiol Renal Physiol 2008;294: F1249-56.
27. Fujihara CK, Velho M, Malheiros DM, et al. An extremely high dose of losartan affords superior renoprotection in the remnant model. Kidney Int 2005;67: 1913-24.
28. Takahashi H, Ichihara A, Kaneshiro Y, et al. Regression of nephropathy developed in diabetes by (Pro)renin receptor blockade. J Am Soc Nephrol 2007;18: 2054-61.
29. Ichihara A, Kaneshiro Y, Takemitsu T, et al. The (pro)renin receptor and the kidney. Semin Nephrol 2007;27: 524-8.
30. Liebau MC, Lang D, Bohm J, et al. Functional expression of the renin-angiotensin system in human podocytes. Am J Physiol Renal Physiol 2006;290: F710-9.
31. Zhang H, Ding J, Fan Q, et al. TRPC6 up-regulation in Ang II-induced podocyte apoptosis might result from ERK activation and NF-kappaB translocation. Exp Biol Med (Maywood) 2009;234: 1029-36.
32. Lai XX, Ding GH, Huang CX, et al. Angiotensin II-induced podocyte apoptosis: role of the MAPK subtypes. Beijing Da Xue Xue Bao 2004;36: 131-4.